Select Page

Market Introduction

The global market for surgical chips is anticipated to surge at a remarkable CAGR throughout the forecast period (2017-2027), asserts Market Research Future (MRFR). A surgical chip is a recognizing coordinated circuit gadget encased in silicate glass and embedded in the body of an individual.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/1310

Key Players

Bio-Rad Laboratories Inc. (US), Cepheid (US), Abbott Laboratories (US) Agilent Technologies, Inc. (US) Perkinelmer Inc. (US), Fluidigm Corporation (US), Illumina Inc. (US), GE Healthcare (UK), Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland) are some of the companies at the forefront of the market.

Market Segmentation

The global surgical chips market has been segmented based on type, end-user, and application.

The types in the global market are DNA Chips, brain chips, lab chips, protein chips, tissue chip and others. The DNA chips market is gaining significant traction from several factors, such as large-scale initiatives in the related field, increasing demand for personalized medicine, miniaturization of DNA chips, escalating need for early detection of cancer and consequent diagnosis and therapeutics.

By end user, the market is segmented into hospitals, clinics, research facilities and others. With constant research and development activities undertaken by companies, number of research facilities have cropped up to meet with these demands. Thus, continuous innovations and discoveries are possible only with high availability of research facilities.

By application, the market is segmented into cancer diagnosis and treatment, gene expression, SNP genotyping, genomics, clinical diagnostics, and others. Rising cases of cancer patients, changing lifestyle and unhealthy eating habits have led to subsequent surge in the cancer diagnosis and treatment market.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/surgical-chips-market-1310

Regional Analysis

The market is regionally split into the regions of the Americas, Europe, Asia Pacific, and Middle East & Africa.

North America is the largest market for surgical chips globally on account of increasing healthcare R&D expenditure and highly enhanced healthcare technology. The need to curtail costs, growth and increased use of shifting commodity prices also work in favor of the regional market.

And Many More.